Fox Chase Cancer Center: Prostatic Neoplasms trials
The registry lists 14 Prostatic Neoplasms studies with Fox Chase Cancer Center as lead sponsor. 1 are open to participants now and 4 have results posted.
Phase 1 1Phase 2 5Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate CancerRecruitingNCT07219303Not applicable
- Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer PatientsCompletedNCT02614859Phase 2Results posted
- Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS)CompletedNCT02224482Not applicableResults posted
- Facilitating Participation in a Prostate Cancer Risk Assessment ProgramCompletedNCT02126319Not applicableResults posted
- Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate CancerCompletedNCT00084552Not applicableResults posted
- African Cancer Genome: GMDCompletedNCT05754658
- Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA MenCompletedNCT01937585Not applicable
- Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community SettingCompletedNCT01440855Not applicable
- Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate CancerWithdrawnNCT00694291Phase 2
- Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
- Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate CancerWithdrawnNCT00084565Phase 2
- Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate CancerCompletedNCT00084526Phase 1/2
- Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00062309Phase 3
- R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00005848Phase 2